-
Despite calls for aggressive action by some epidemiologists, new draft federal guidelines on multidrug-resistant organisms (MDROs) argue against adoption of the most comprehensive methods as the sole approach to this problem.
-
Denise Murphy, RN, MPH, CIC, chief of patient safety at Barnes Jewish Hospital at Washington University Medical Center in St. Louis, and colleagues developed the following scenarios to assist infection control professionals in identifying sentinel events related to infections.
-
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA).
-
The results of two recent Phase III clinical trials indicate that docetaxel (Taxotere) extends life in advanced prostate cancer patients who are resistant to hormone therapy, supporting the Food and Drug Administrations approval of docetaxel injection, in combination with prednisone, for the treatment of patients with advanced metastatic prostate cancer.
-
The Institute for Safe Medication Practices (ISMP) in Huntingdon Valley, PA, is encouraging pharmacists to help conduct a self-assessment of their hospitals medication safety processes. Data from the surveys then will be compiled and analyzed so that participating hospitals can compare their results against demographically similar institutions.
-
-
Grant Wicklund has joined MedCath (Charlotte, North Carolina) as senior vice president and chief administrative officer. Wicklund, who will be responsible for human resources, managed care, materials management/purchasing, administration and MedCaths Cardiology Consulting & Management division, previously was with Tenet Healthcare.
-
The Department of Health and Human Services (HHS) reported last month that it will form a multi-department task force charged with speeding the development of medical technology. The
-
Two companies received FDA clearance last month for new cardiac diagnostic tests that could greatly aid in the rapid detection of a potential heart attack, and one in particular could be the wave of the future for emergency room diagnosis of that condition.
-
Cardiovasular device powerhouse Guidant (Indianapolis, Indiana) reported on May 18 that Ronald Dollens, the companys president and chief executive officer and a guiding force for the company since its founding, will retire on Dec. 31. The announcement came as a surprise to most industry watchers.
